3.1.3.74	drug development	important in vitamin B6 metabolism	
3.1.3.74	drug development	possibility of development of the pyridoxine production process by a metabolic engineering approach. In the future, overexpression of the pdxP gene in combination with another pyridoxine gene will be necessary to develop even more efficient processes for production of vitamin B6	
3.1.3.74	drug development	transduction of the PEP-1-PLPP fusion protein into cells would be useful as therapeutic agent for various disorders related to this enzyme and vitamin B6	
3.1.3.74	additional information	hypothetical protein Q8CHP8 shows 44-47% sequence identity to pyridoxal phosphate phosphatase